Nath Bio-Genes (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has informed the exchanges that the trading window for dealing in its shares will be closed from Tuesday, 1st July 2025 until 48 hours after the declaration of unaudited financial results for the quarter ended 30th June 2025. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's own insider trading code. The date of the board meeting to approve the Q1 FY26 results has not yet been announced and will be communicated separately. The intimation was signed by the Chief Financial Officer, Amol Gupta, on 27th June 2025.
This is a routine regulatory filing and not a material event. The trading window closure prevents insiders from trading ahead of the Q1 results announcement, but it does not impact the business or stock price. Investors should watch for the upcoming board meeting date for the Q1 results, which will be the next key event.